| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN504MU2003IN2003MU00504A (en) | 2003-06-05 | 2003-06-05 | |
| DE602004005709TDE602004005709T2 (en) | 2003-06-05 | 2004-05-14 | OSMO MICROSOUS PREPARATION WITH EXTENDED RELEASE OF VENA FAXINE |
| EP04770652AEP1633330B1 (en) | 2003-06-05 | 2004-05-14 | Extended release osmo-microsealed formulation |
| PCT/IN2004/000133WO2004108117A2 (en) | 2003-06-05 | 2004-05-14 | Extended release osmo-microsealed formulation comprising venlafaxine |
| ES04770652TES2286676T3 (en) | 2003-06-05 | 2004-05-14 | OSMOMICROSELLED FORMULATION OF PROLONGED RELEASE. |
| AT04770652TATE358472T1 (en) | 2003-06-05 | 2004-05-14 | OSMO-MICROLOCKED EXTENDED RELEASE PREPARATION OF VENLAFAXINE |
| US10/563,631US20070110808A1 (en) | 2003-06-05 | 2004-05-14 | Extended release osmo-microsealed formulation |
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN504MU2003IN2003MU00504A (en) | 2003-06-05 | 2003-06-05 |
| Publication Number | Publication Date |
|---|---|
| IN2003MU00504Atrue IN2003MU00504A (en) | 2005-05-13 |
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN504MU2003IN2003MU00504A (en) | 2003-06-05 | 2003-06-05 |
| Country | Link |
|---|---|
| US (1) | US20070110808A1 (en) |
| EP (1) | EP1633330B1 (en) |
| AT (1) | ATE358472T1 (en) |
| DE (1) | DE602004005709T2 (en) |
| ES (1) | ES2286676T3 (en) |
| IN (1) | IN2003MU00504A (en) |
| WO (1) | WO2004108117A2 (en) |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20020059653A (en) | 1999-10-29 | 2002-07-13 | 그린 마틴, 브라이언 쥐 테슬리 | Controlled release hydrocodone formulations |
| US10179130B2 (en) | 1999-10-29 | 2019-01-15 | Purdue Pharma L.P. | Controlled release hydrocodone formulations |
| EP2295042A1 (en) | 2000-10-30 | 2011-03-16 | Euro-Celtique S.A. | Controlled release hydrocodone formulations |
| CA2595988A1 (en) | 2005-01-27 | 2006-08-03 | Alembic Limited | Extended release formulation of levetiracetam |
| CA2578626C (en) | 2005-06-27 | 2011-07-19 | Biovail Laboratories International S.R.L. | Modified-release formulations of a bupropion salt |
| WO2007052299A2 (en)* | 2005-08-24 | 2007-05-10 | Rubicon Research Pvt Ltd. | Controlled release formulation |
| KR101324898B1 (en)* | 2006-03-31 | 2013-11-04 | 루비콘 리서치 피브이티. 엘티디. | Orally disintegrating tablets |
| GB0610570D0 (en)* | 2006-05-27 | 2006-07-05 | Pliva Istrazivanje I Razvoj D | Novel formulation |
| US8445018B2 (en) | 2006-09-15 | 2013-05-21 | Cima Labs Inc. | Abuse resistant drug formulation |
| WO2008079342A2 (en)* | 2006-12-21 | 2008-07-03 | Mallinckrodt Inc. | Composition of and method for preparing orally disintegrating tablets |
| US20080245273A1 (en)* | 2007-04-05 | 2008-10-09 | Jouko Vyorkka | Hydrophobic coatings |
| WO2009155488A2 (en)* | 2008-06-19 | 2009-12-23 | Segrub, Llc | Novel oxalate salt and crystal of o-desmethylvenlafaxine |
| CA2749933A1 (en)* | 2009-02-04 | 2010-08-12 | Supernus Pharmaceuticals, Inc. | Formulations of desvenlafaxine |
| JP5055397B2 (en)* | 2010-03-10 | 2012-10-24 | 株式会社ユニックスジャパン | Dental molded body and dental resin material |
| WO2011143119A1 (en)* | 2010-05-11 | 2011-11-17 | Cima Labs Inc. | Alcohol-resistant extended release dosage forms comprising venlafaxine |
| WO2011143120A1 (en) | 2010-05-11 | 2011-11-17 | Cima Labs Inc. | Alcoholres i stant metoprolol - containing extended - release oral dosage forms |
| US20150275167A1 (en)* | 2014-03-28 | 2015-10-01 | Corning Incorporated | Composition and method for cell culture sustained release |
| CN106236739B (en)* | 2016-07-27 | 2019-06-07 | 上海宣泰生物科技有限公司 | Contain lutein/lutein ester composition and its application |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6274171B1 (en)* | 1996-03-25 | 2001-08-14 | American Home Products Corporation | Extended release formulation of venlafaxine hydrochloride |
| PE57198A1 (en)* | 1996-03-25 | 1998-10-10 | American Home Prod | PROLONGED RELEASE FORMULA |
| CA2216215A1 (en)* | 1997-04-05 | 1998-10-05 | Isa Odidi | Controlled release formulations using intelligent polymers having opposing wettability characteristics of hydrophobicity and hydrophilicity |
| US6248363B1 (en)* | 1999-11-23 | 2001-06-19 | Lipocine, Inc. | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
| US6572890B2 (en)* | 2000-01-13 | 2003-06-03 | Osmotica Corp. | Osmotic device containing venlafaxine and an anti-psychotic agent |
| US6352721B1 (en)* | 2000-01-14 | 2002-03-05 | Osmotica Corp. | Combined diffusion/osmotic pumping drug delivery system |
| US20030091634A1 (en)* | 2001-09-14 | 2003-05-15 | Pawan Seth | Delayed release tablet of venlafaxin |
| Publication number | Publication date |
|---|---|
| US20070110808A1 (en) | 2007-05-17 |
| WO2004108117A3 (en) | 2005-09-15 |
| EP1633330A2 (en) | 2006-03-15 |
| DE602004005709T2 (en) | 2008-01-24 |
| DE602004005709D1 (en) | 2007-05-16 |
| ATE358472T1 (en) | 2007-04-15 |
| ES2286676T3 (en) | 2007-12-01 |
| EP1633330B1 (en) | 2007-04-04 |
| WO2004108117A2 (en) | 2004-12-16 |